Dr. Maya R. Jerath, MD
Allergy & Immunology (Allergy & Immunology (Internal Medicine) Physician)
10 Barnes West Dr, Div Im Allergy And Immunology, Ste 200
Saint Louis, MO 63141
Who else practices at this address →
St. Louis County includes dental (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Vermont College of Medicine (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 287
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: University of Vermont College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Allergy & Immunology (Internal Medicine) Physician primary
MO license 2017029353
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Barnes Jewish Hospital Saint Louis, MO
- Barnes-Jewish West County Hospital Creve Coeur, MO
Medical groups
- Washington University (3,029 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 287
- Services billed
- 40,153
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Injection, vedolizumab, 1 mg | 7,200 | 12 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 4,800 | 23 |
| Injection, denosumab, 1 mg | 2,460 | 39 |
| Injection, omalizumab, 5 mg | 2,325 | 13 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 157 | 38 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 155 | 74 |
| Professional service for multiple injections of allergen | 131 | 41 |
| Injection of drug or substance under skin or into muscle | 105 | 67 |
| Test to measure expiratory airflow and volume | 54 | 49 |
| Test to examine how well the lungs exchange gases | 51 | 51 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Azelastine Hcl Other prescribers in Saint Louis, MO | 74 |
| Hydroxychloroquine Sulfate Other prescribers in Saint Louis, MO | 55 |
| Montelukast Sodium Other prescribers in Saint Louis, MO | 53 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Saint Louis, MO | 37 |
| Cromolyn Sodium | 37 |
| Fluticasone Propionate Other prescribers in Saint Louis, MO | 37 |
| Ipratropium Bromide Other prescribers in Saint Louis, MO | 32 |
| Budesonide-Formoterol Fumarate (budesonide/formoterol fumarate) Other prescribers in Saint Louis, MO | 26 |
| Epinephrine Other prescribers in Saint Louis, MO | 24 |
| Dupixent Syringe (dupilumab) Other prescribers in Saint Louis, MO | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 8 payments worth $536 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $466 |
|---|---|
| Genzyme Corporation | $37.73 |
| Pfizer Inc. | $32.39 |
| Food and Beverage | $536 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $119,954 in research payments for these studies, mostly to the institutions running them.
- Aumlticentre,randomised,open label,parallel group,phase IIIb study to assess the potential for tezepelumab treatedtie pants with severe asthma to reduce background therapy while sustaining asthma control and clinical …
AstraZeneca Pharmaceuticals LP - A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Contro…
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.